Get Published | Subscribe | About | Write for Our Blog    

News RSS Bioethics News.


The Next Phase of Human Gene-Therapy Oversight

External Link - Source: The New England Journal of Medicine

The NIH envisions using the RAC as an advisory board on to- day’s emerging biotechnologies, such as gene editing, synthetic bi- ology, and neurotechnology, while harnessing the attributes that have long ensured its transparency. We at the NIH and the FDA look for- ward to working together with all our stakeholders to implement thesechanges.Wesharecommon goals: advancing science and hu- man health and accelerating the availability of safe and effective gene therapy, along with the many promising new products that fu- ture biotechnologies may bring.